Clinical Trial Update: Treatment of Colorectal Liver Metastases With Immunotherapy and Bevacizumab [Phase 2]

View source ↗

Summary

Phase 2 trial investigating immunotherapy plus bevacizumab for colorectal liver metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Liver Metastasis
• Colorectal Neoplasms

Drugs mentioned

• Bevacizumab (bevacizumab)
• Immunotherapy (immunotherapy)

Snippet

Sponsor: Asan Medical Center | Conditions: Colorectal Neoplasms, Neoplasm Metastasis | Phase 2 | Status: COMPLETED